FDA Adverse Event Malfunction Summary report: N

COBAS 8000 CORE UNIT

MDR report key: 8514376 · Received April 15, 2019

Report

Report Number
1823260-2019-01452
Event Type
Malfunction
Date Received
April 15, 2019
Date of Event
March 13, 2019
Report Date
April 15, 2019
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE INITIAL REPORTER RECEIVED QUESTIONABLE ISE INDIRECT GEN.2 RESULTS FOR ONE PATIENT FROM A COBAS 8000 ANALYZER COMPARED TO A VITROS ANALYZER AND A BLOODGAS ANALYZER OVER SEVERAL DAYS. THE CUSTOMER SUSPECTED INTERFERENCE DUE TO THE MEDICATION FLAMMACERIUM TAKEN BY THE PATIENT. IT WAS UNCLEAR IF THE SAME SAMPLE WAS USED FOR TESTING ON THE DIFFERENT ANALYZERS. THE SODIUM RESULTS FROM THE COBAS 8000 ANALYZER WERE 151-153 MMOL/L. THE SODIUM RESULTS FROM THE OTHER ANALYZER WERE 144-148 MMOL/L. THE POTASSIUM RESULTS FROM THE COBAS 8000 ANALYZER WERE 3.4-5.6 MMOL/L. THE POTASSIUM RESULTS FROM THE OTHER ANALYZER WERE 3.4-5.1 MMOL/L. THE CHLORIDE RESULTS FROM THE COBAS 8000 ANALYZER WERE 102-125 MMOL/L. THE CHLORIDE RESULTS FROM THE OTHER ANALYZER WERE 117-123 MMOL/L. THE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE ELECTRODE LOT NUMBERS AND EXPIRATION DATES WERE REQUESTED BUT WERE NOT PROVIDED. AS ALL ISE PARAMETERS APPEARED TO BE AFFECTED, DIRECT INTERFERENCE CAUSED BY FLAMMACERIUM COULD BE EXCLUDED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
308267 COBAS 8000 CORE UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS COBAS 8000 CORE NA

Patients

Seq Age Sex Outcome Treatment
1 FLAMMACERIUM